Syndax Pharmaceuticals Statistics
Total Valuation
SNDX has a market cap or net worth of $1.25 billion. The enterprise value is $1.28 billion.
| Market Cap | 1.25B |
| Enterprise Value | 1.28B |
Important Dates
The next estimated earnings date is Monday, November 2, 2026, after market close.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SNDX has 89.30 million shares outstanding. The number of shares has increased by 1.95% in one year.
| Current Share Class | 89.30M |
| Shares Outstanding | 89.30M |
| Shares Change (YoY) | +1.95% |
| Shares Change (QoQ) | +0.83% |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | 114.17% |
| Float | 80.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.82 |
| Forward PS | n/a |
| PB Ratio | 97.72 |
| P/TBV Ratio | 80.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.77, with a Debt / Equity ratio of 39.03.
| Current Ratio | 6.77 |
| Quick Ratio | 6.29 |
| Debt / Equity | 39.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.58 |
Financial Efficiency
Return on equity (ROE) is -255.93% and return on invested capital (ROIC) is -21.92%.
| Return on Equity (ROE) | -255.93% |
| Return on Assets (ROA) | -18.67% |
| Return on Invested Capital (ROIC) | -21.92% |
| Return on Capital Employed (ROCE) | -32.15% |
| Weighted Average Cost of Capital (WACC) | 6.29% |
| Revenue Per Employee | $846,480 |
| Profits Per Employee | -$740,822 |
| Employee Count | 298 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 8.76 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.14% in the last 52 weeks. The beta is 0.42, so SNDX's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -13.14% |
| 50-Day Moving Average | 18.85 |
| 200-Day Moving Average | 20.72 |
| Relative Strength Index (RSI) | 22.36 |
| Average Volume (20 Days) | 2,215,438 |
Short Selling Information
The latest short interest is 18.23 million, so 20.42% of the outstanding shares have been sold short.
| Short Interest | 18.23M |
| Short Previous Month | 20.66M |
| Short % of Shares Out | 20.42% |
| Short % of Float | 22.71% |
| Short Ratio (days to cover) | 10.06 |
Income Statement
In the last 12 months, SNDX had revenue of $252.25 million and -$220.77 million in losses. Loss per share was -$2.51.
| Revenue | 252.25M |
| Gross Profit | -20.20M |
| Operating Income | -194.17M |
| Pretax Income | -220.77M |
| Net Income | -220.77M |
| EBITDA | -194.16M |
| EBIT | -194.17M |
| Loss Per Share | -$2.51 |
Balance Sheet
The company has $554.27 million in cash and $589.38 million in debt, with a net cash position of -$35.12 million or -$0.39 per share.
| Cash & Cash Equivalents | 554.27M |
| Total Debt | 589.38M |
| Net Cash | -35.12M |
| Net Cash Per Share | -$0.39 |
| Equity (Book Value) | 15.10M |
| Book Value Per Share | 0.17 |
| Working Capital | 575.36M |
Cash Flow
In the last 12 months, operating cash flow was -$220.64 million and capital expenditures -$227,000, giving a free cash flow of -$220.87 million.
| Operating Cash Flow | -220.64M |
| Capital Expenditures | -227,000 |
| Depreciation & Amortization | 11,000 |
| Net Borrowing | 243.85M |
| Free Cash Flow | -220.87M |
| FCF Per Share | -$2.47 |
Margins
Gross margin is -8.01%, with operating and profit margins of -76.98% and -87.52%.
| Gross Margin | -8.01% |
| Operating Margin | -76.98% |
| Pretax Margin | -87.52% |
| Profit Margin | -87.52% |
| EBITDA Margin | -76.97% |
| EBIT Margin | -76.98% |
| FCF Margin | n/a |
Dividends & Yields
SNDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.95% |
| Shareholder Yield | -1.95% |
| Earnings Yield | -18.16% |
| FCF Yield | -18.17% |
Analyst Forecast
The average price target for SNDX is $37.27, which is 167.17% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $37.27 |
| Price Target Difference | 167.17% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 55.63% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SNDX has an Altman Z-Score of -1.37 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.37 |
| Piotroski F-Score | 4 |